Viking Therapeutics (VKTX) is down -42.6%, or -$17.93 to $24.16.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Viking Therapeutics drop may be partially ‘sell the news,’ says H.C. Wainwright
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Positive Buy Rating for Viking Therapeutics Driven by Promising VK2735 Trial Results and Market Potential
- Viking Therapeutics falls -40.1%
- Morning Movers: Nexstar and Tegna jump following merger deal
